Recent trading performance for Rocket Lab stock

Rocket Lab (RKLB) has attracted attention after a choppy stretch in the share price, with the stock down 5.5% over the past day and 24.8% over the past week.

Over the past month the stock has fallen 43.7%. However, it remains up 32.4% over the past 3 months and 123.3% over the past year, highlighting how volatile the ride has been for investors.

Year to date, Rocket Lab is up 6.2%, with a market value of about US$49.4b based on the last close of US$80.69. This keeps the company firmly in the spotlight among space-related stocks.

For Rocket Lab, the sharp 43.7% decline in the 1 month share price return contrasts with its very large 1 year and 3 year total shareholder returns. This suggests that recent momentum is fading after an extended period of strong gains.

If you want to see how other space related and adjacent companies are priced after similar swings, it could be worth scanning 29 quantum computing stocks

With Rocket Lab now giving back a chunk of its recent gains, the key question is whether the current share price reflects a rare discount on future potential or whether the market is already pricing in the growth story.

Most Popular Narrative: 5.1% Undervalued

Based on the most widely followed narrative, Rocket Lab’s fair value of $85.04 sits slightly above the last close at $80.69, which frames the current pullback as a modest discount rather than a reset.

Rocket Lab is mid-transformation from a small-launch specialist into a vertically integrated space and defense prime, with Space Systems now ~67% of revenue and growing fastest.

A $1.85B backlog (+73% YoY) anchored by the $816M SDA Tranche 3 award provides multi-year revenue visibility that the current trailing P/S of ~72x does not yet fully reflect.

Curious what underpins that $85.04 fair value for Rocket Lab? The narrative leans heavily on rapid revenue expansion, improving margins, and a future cash flow profile that looks very different to today’s losses.

Result: Fair Value of $85.04 (UNDERVALUED)

However, Rocket Lab’s story can quickly change if Neutron suffers fresh delays or if heavy reliance on large defense contracts leads to unexpected order deferrals.

Another View: Rocket Lab through a cash flow lens

While the dominant narrative frames Rocket Lab as modestly undervalued around a fair value of $85.04, our DCF model presents a more cautious perspective, with a future cash flow value of $73.14 versus the current $80.69 share price. This comparison suggests that the stock may be trading at a premium instead.

That gap does not prove the story is wrong, but it does highlight how sensitive Rocket Lab is to assumptions about future growth, margins, and execution on projects like Neutron. Which view do you think better matches your risk tolerance?

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Rocket Lab for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 43 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

With sentiment on Rocket Lab clearly mixed, this is the moment to move fast, review the key data, and decide where you stand based on 1 key reward and 3 important warning signs.

Looking for more investment ideas beyond Rocket Lab?

If Rocket Lab has sharpened your focus, do not stop here. Broader opportunities across sectors can help balance your watchlist and sharpen your next move.

• Target long term compounding potential by scanning companies that look attractively priced using the 43 high quality undervalued stocks.
• Strengthen your downside protection by focusing on resilient businesses through the 67 resilient stocks with low risk scores.
• Hunt for underfollowed opportunities before the crowd arrives by reviewing the screener containing 19 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.